Neural Induction with Neurogenin 1 Enhances the Therapeutic Potential of Mesenchymal Stem Cells in an Amyotrophic Lateral Sclerosis Mouse Model
Amyotrophic lateral sclerosis (ALS) is characterized by progressive dysfunction and degeneration of motor neurons in the central nervous system (CNS). In the absence of effective drug treatments for ALS, stem cell treatment has emerged as a candidate therapy for this disease. To date, however, there...
Main Authors: | Chan-Il Choi, Young-Don Lee, Heejaung Kim, Seung Hyun Kim, Haeyoung Suh-Kim PhD, Sung-Soo Kim Ph.D. |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-05-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368912X637019 |
Similar Items
-
Amyotrophic lateral sclerosis is associated with hypolipidemia at the presymptomatic stage in mice.
by: Sung-Min Kim, et al.
Published: (2011-01-01) -
Comparison of MSC-Neurogenin1 administration modality in MCAO rat model
by: Shin Dong Hoon, et al.
Published: (2016-12-01) -
Development of an electrooculogram-based eye-computer interface for communication of individuals with amyotrophic lateral sclerosis
by: Won-Du Chang, et al.
Published: (2017-09-01) -
Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole
by: Corcia P, et al.
Published: (2012-08-01) -
The follow-up study on patients of Amyotrophic lateral sclerosis
by: Song Bong-kuen, et al.
Published: (2010-03-01)